Pfizer's updated Covid vaccine effective against 'Eris' variant in mice study

Posted on:
Key Points

EG.5, nicknamed by some as "Eris", is similar to the XBB.1.5 subvariant and a sub-lineage of the still-dominant Omicron variant...

Pfizer Inc said on Thursday its updated COVID-19 shot, which is being tested against emerging variants, showed neutralizing activity against the "Eris" subvariant in a study conducted on mice.S)..

Pfizer, along with its German partner BioNTech SE, as well as other COVID-19 vaccine makers Moderna and Novavax have created versions of their shots, which are aimed at the XBB.1.5 subvariant..

Full story at Hindustan Times | 

You might be interested in

Biological E bags CDSCO nod for clinical trials on nextgen XBB1.5 Covid-19 variant vax

16, Jan, 24

HYDERABAD: Amid rising cases of Covid-19 globally, especially those of Omicron subvariants such as JN.

Read at Times Of India Key Points

Novavax exec says its new COVID shot should work against variants on the rise

06, Jun, 23

Novavax Inc's head of research and development on Monday said an updated COVID-19 vaccine the company is already producing is likely to be protective against other fast-growing coronavirus variants circulating in the U.S.

Read at Reuters Key Points